NovoCure Ltd (NVCR)
12.64
+0.41
(+3.35%)
USD |
NASDAQ |
Apr 26, 16:00
12.64
0.00 (0.00%)
After-Hours: 20:00
NovoCure Total Liabilities (Quarterly): 783.63M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 783.63M |
| September 30, 2023 | 752.65M |
| June 30, 2023 | 743.33M |
| March 31, 2023 | 742.19M |
| December 31, 2022 | 750.48M |
| September 30, 2022 | 728.81M |
| June 30, 2022 | 721.00M |
| March 31, 2022 | 714.33M |
| December 31, 2021 | 729.00M |
| September 30, 2021 | 707.29M |
| June 30, 2021 | 699.79M |
| March 31, 2021 | 695.50M |
| December 31, 2020 | 575.46M |
| September 30, 2020 | 124.01M |
| June 30, 2020 | 261.12M |
| March 31, 2020 | 260.50M |
| December 31, 2019 | 261.66M |
| September 30, 2019 | 253.49M |
| Date | Value |
|---|---|
| June 30, 2019 | 247.28M |
| March 31, 2019 | 243.86M |
| December 31, 2018 | 227.53M |
| September 30, 2018 | 200.58M |
| June 30, 2018 | 197.80M |
| March 31, 2018 | 197.36M |
| December 31, 2017 | 151.73M |
| September 30, 2017 | 145.59M |
| June 30, 2017 | 139.50M |
| March 31, 2017 | 135.73M |
| December 31, 2016 | 139.74M |
| September 30, 2016 | 132.85M |
| June 30, 2016 | 63.87M |
| March 31, 2016 | 58.59M |
| December 31, 2015 | 56.52M |
| September 30, 2015 | 52.56M |
| June 30, 2015 | 48.46M |
| December 31, 2014 | 20.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
124.01M
Minimum
Sep 2020
783.63M
Maximum
Dec 2023
565.87M
Average
707.29M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| AtriCure Inc | 147.76M |
| NeuroMetrix Inc | 1.333M |
| Repligen Corp | 853.21M |
| Teleflex Inc | 3.092B |
| Perspective Therapeutics Inc | 22.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.146B |
| Shareholders Equity (Quarterly) | 362.50M |
| Debt to Equity Ratio | 1.569 |
| Current Ratio | 5.775 |
| Net Debt Paydown Yield | -0.05% |